Still River names Jachinowski CEO

Justine Varieur Cadet | | Health Imaging | Oncology Imaging
Still River Systems, a developer of proton therapy systems for cancer treatment, has appointed Joseph K. Jachinowski as its CEO and to its board of directors.

Most recently, he was the executive vice president of the Stockholm, Sweden-based Elekta and CEO of Elekta Holdings with responsibility for Elekta's North American operations. Prior to Elekta, he co-founded Impac Medical Systems and served as its President and CEO for 15 years from its inception. Jachinowski began his career at Varian Medical Systems, where he was responsible for leading the team that developed their linear accelerator products in the 1980s.

In related news, Littleton, Mass.-based Still River said that Marc Buntaine will be assuming the position of president and chief commercial officer, and Kenneth Gall, PhD, a company founder, has been named chief technology officer.

Justine Varieur Cadet

Related Content

MRI guidance significantly reduces radiotherapy side effects compared to CT
Interventional procedure often as effective as surgery for difficult-to-treat liver cancer
AI tumor volume estimations could improve prostate cancer treatment strategies
MRI could be 'powerful tool' for guiding surgery decisions in patients with rectal cancer
Breast cancer only visible via MRI is often less aggressive
Breast cancer rates are on the rise, new report reveals

Around the web

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.